It digests and metabolizes oxalate, preventing high urine oxalate and calcium oxalate kidney stones (Mogna 2014
The blank days are deliberate there is no daily dosing here
A recent Phase 2 randomised placebo-controlled trial tested efinopegdutide in people with obesity over a 26-week period, where participants were randomly assigned weekly treatment with either placebo, 5 mg, 7.4 mg, 10 mg efinopegdutide, or 3 mg liraglutide daily
Planning ahead From an aesthetic perspective, the priority should be to plan rather than panic
Clinical data suggests that GIP co-activation with GLP-1 may also reduce nausea rates compared to GLP-1 stimulation alone, which could explain why Retatrutide and Tirzepatide cause less nausea than Semaglutide despite being more potent compounds
Q: Are there side effects to GLP-1 Therapy